The key with PAA is that they've been able to demonstrate that their new anti-cancer drug has little or no toxicity.
There is not a single anti-cancer drug in the world that has such low levels of toxicity.
What began as an accidental discovery is fast becoming a serious, potentially ground-breaking drug in the oncology space... and in a $42bn per annum industry.. this is the space to be in.
